C B PHARMA ACQUISITION CORP's ticker is CNLMU and the CUSIP is G2029P100. A total of 13 filers reported holding C B PHARMA ACQUISITION CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $3,577,000 | -1.7% | 350,000 | 0.0% | 0.06% | 0.0% |
| Q3 2015 | $3,640,000 | -0.8% | 350,000 | 0.0% | 0.06% | +6.7% |
| Q2 2015 | $3,668,000 | +2.5% | 350,000 | 0.0% | 0.06% | -21.1% |
| Q1 2015 | $3,577,000 | +1.9% | 350,000 | 0.0% | 0.08% | +15.2% |
| Q4 2014 | $3,511,000 | – | 350,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENECA CAPITAL INVESTMENTS, L.P. | 150,000 | $1,570,000 | 0.56% |
| GLAZER CAPITAL, LLC | 217,148 | $2,161,000 | 0.27% |
| Polar Asset Management Partners Inc. | 200,000 | $2,092,000 | 0.13% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 350,000 | $3,640,000 | 0.06% |
| GOLDMAN SACHS GROUP INC | 17,500 | $182,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 320 | $3,000 | 0.00% |
| UBS Group AG | 210 | $2,000 | 0.00% |